Collaborate Disseminate
A new study from Stanford University researchers has found previous recent exposure to common coronaviruses could help explain why some people infected with SARS-CoV-2 only suffer mild symptoms. The research showed specific immune cells from patients w… Continue reading Mild COVID-19 symptoms linked to prior exposure to the common cold
An impressive new study has highlighted the gut-brain link between social behavior and gut microbes in mice. The thorough research shows how lacking certain gut bacteria can increase levels of a hormone that directly activates part of the brain that co… Continue reading Compelling new clues to how gut bacteria can influence social behavior
Late in 2020, two experimental mRNA COVID-19 vaccines delivered stunningly positive final phase human trial results. With efficacy higher than 90 percent, the Pfizer and Moderna vaccines introduced the world to an entirely new kind of biotechnology, an… Continue reading Once-promising mRNA COVID-19 vaccine disappoints with final trial data
An extraordinary new study has detailed the development of a nearly complete mouse embryo – with muscles, blood vessels and a tiny beating heart – grown in a lab dish out of stem cells. The research presents the most sophisticated “embryo in a dish” cr… Continue reading Scientists create mouse embryo with a beating heart from stem cells
New research is showing that although some vaccinated people are still contracting COVID-19, they generally experience milder disease for a shorter period of time with a low viral load. The study, published in the New England Journal of Medicine, offer… Continue reading COVID-19 infections are rare and mild after vaccination
After years of preclinical work, Japanese researchers have announced a new kind of drug treatment for dementia and Alzheimer’s disease is ready to move to human clinical trials. A number of animal studies have shown the novel drug to improve cognition and reduce signs of neurodegeneration in a number of dementia-causing diseases.
Category: Health & Wellbeing, Lifestyle
Tags: Neuroscience, Dementia, Alzheimer’s Disease, Parkinson’s Disease, Brain, Tohoku University, New Atlas Audio
Continue reading Dementia-fighting experimental drug moves to human trials
Researchers investigating new diabetes treatments believe they have found evidence indicating excess production of a key neurotransmitter in the liver could be a key causal factor in the onset of insulin resistance. The discovery points to novel preven… Continue reading New clues point to the liver playing a causal role in type 2 diabetes
Researchers from MIT and Harvard have demonstrated a cutting-edge biosensor technology by developing a face mask that can detect SARS-CoV-2 in a wearer’s breath within just 90 minutes. The sensor technology can be programmed to detect any kind of virus… Continue reading MIT and Harvard engineers develop face mask that detects COVID-19
Researchers from Brigham and Women’s Hospital have engineered yeast used in baking, wine-making and brewing to treat inflammatory bowel disease (IBD). The bacteria has been modified to secrete an anti-inflammatory molecule in response to signs of gut i… Continue reading Beer yeast genetically engineered to detect and treat gut inflammation
Japanese researchers have developed a new type of cholera vaccine by genetically modifying rice to carry a non-toxic cholera antigen. The vaccine needs no refrigeration with the rice simply ground into a powder, mixed with water and consumed.Continue R… Continue reading Genetically modified rice used for edible, easily stored cholera vaccine